
A new federal artificial intelligence initiative, called Stargate, will receive up to $500 billion in investment for AI infrastructure development in the United States. Oracle CEO Larry Ellison highlighted the project’s potential application in developing personalized mRNA cancer vaccines, suggesting a 48-hour turnaround time from detection to vaccine production using AI-driven processes and robotics.
Key Points:
- The White House announced a partnership with major tech companies including Oracle, Microsoft, NVIDIA, and OpenAI, starting with an initial $100 billion investment that could expand to $500 billion
- Oracle CEO Larry Ellison described an AI-enabled blood testing system for early cancer detection, coupled with rapid personalized mRNA vaccine production within 48 hours
- The project anticipates creating more than 100,000 American jobs “almost immediately,” according to the announcement
- SoftBank CEO Masayoshi Son committed $100 billion to US projects over the next four years, building on previous investments
- Tesla CEO Elon Musk questioned the financial backing, stating SoftBank has “well under $10B secured”

“You can make that vaccine, that mRNA vaccine, you can make that robotically, again using AI, in about 48 hours. So imagine early cancer detection, the development of a cancer vaccine for your particular cancer, aimed at you, and have that vaccine available in 48 hours.”
— Larry Ellison, Oracle CEO
Personalized Medicine Summaries